Omnicell, Inc. - Common Stock (OMCL)
36.65
-0.23 (-0.62%)
NASDAQ · Last Trade: Nov 1st, 5:10 PM EST
News & Press Releases
Omnicell Q3 Earnings Call Highlightsmarketbeat.com
Omnicell (NASDAQ:OMCL) reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan XT automated dispensing hardware and remains on track for first-half 2027 general availability of it
Via MarketBeat · October 29, 2026
Omnicell (OMCL) Q3 2026 Earnings Call Transcriptfool.com
EPS surpassed guidance on cost discipline and favorable customer mix.
Via The Motley Fool · October 29, 2026
Omnicell (NASDAQ:OMCL) Profit Beat and Raised Guidance Offset Soft Q4 Revenue Outlookchartmill.com
Via Chartmill · October 29, 2026
Omnicell (NASDAQ:OMCL) exceeds Q3 2026 expectations but quarterly revenue guidance misses expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q3 2026, but revenue was flat year on year at $307.9 million. On the...
Via StockStory · October 29, 2026
Robotics Earnings Week: Momentum vs. Value as Four Automation Names Reportchartmill.com
Via Chartmill · September 25, 2026
Three Earnings Reports Put the Automation Rally to the Testchartmill.com
Via Chartmill · August 27, 2026
Omnicell (NASDAQ:OMCL) Q2 Earnings Beat Overshadowed by Disappointing Guidancechartmill.com
Via Chartmill · July 30, 2026
Omnicell Announces Third Quarter 2026 Financial Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” or the “Company”), a healthcare technology leader focused on advancing autonomous medication management, today reported financial results for the third quarter ended September 30, 2026.
By Omnicell, Inc. · Via Business Wire · October 29, 2026
Omnicell earnings: what to look for from OMCL
Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting earnings this Thursday before market hours. Here’s what to expect. Omnicell beat analysts’ r...
Via StockStory · October 27, 2026
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via StockStory · October 21, 2026
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2026, before market open on Thursday, October 29, 2026. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
By Omnicell, Inc. · Via Business Wire · October 8, 2026
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via StockStory · October 6, 2026
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...
Via StockStory · October 4, 2026
3 Reasons OMCL is Risky and 1 Stock to Buy Instead
Omnicell has been treading water for the past six months, recording a small loss of 4.6% while holding steady at $32.74. The stock also fell short of the S&P...
Via StockStory · September 21, 2026
1 Cash-Heavy Stock to Target This Week and 2 We Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via StockStory · September 11, 2026
1 Cash-Producing Stock on Our Buy List and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...
Via StockStory · September 10, 2026
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 12:45p.m. EDT.
By Omnicell, Inc. · Via Business Wire · August 31, 2026
3 Small-Cap Stocks We Approach with Caution
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via StockStory · August 23, 2026
Omnicell President Sells 6,753 Sharesfool.com
Nnamdi Njoku's disposal reduced his direct holdings by 4%, with over half tied to tax withholding from RSU vesting. He retains ~161,223 shares worth $5.81 million.
Via The Motley Fool · August 20, 2026
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
EnlivenHealth, Inc., a subsidiary of Omnicell, Inc. (“EnlivenHealth”) and a leading innovator in pharmacy technology and patient engagement solutions, today announced the launch of VaxReach, a proactive vaccine outreach program designed to help pharmacies identify eligible patients and automatically reach them with timely messages that are intended to drive more vaccine traffic into the store. The company will highlight the program at ThoughtSpot 2026, as pharmacies prepare for respiratory and flu season, looking for potentially more efficient ways to turn vaccine opportunities into in-store vaccinations.
By Omnicell, Inc. · Via Business Wire · July 30, 2026
Omnicell Q2 Earnings Call Highlightsmarketbeat.com
Omnicell (NASDAQ:OMCL) reported second-quarter 2026 revenue at the high end of its prior outlook and profitability above expectations, while widening its full-year product bookings range to reflect uncertainty in the timing of customer purchasing decisions for large medication-management platform in
Via MarketBeat · July 30, 2026
Omnicell (OMCL) Stock Trades Down, Here Is Why
What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 9.9% in the afternoon session after the company issued weak guidance for the upc...
Via StockStory · July 30, 2026
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.4% year on year to $312.2 million. On th...
Via StockStory · July 30, 2026
Omnicell Announces Second Quarter 2026 Financial Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today reported financial results for the second quarter ended June 30, 2026.
By Omnicell, Inc. · Via Business Wire · July 30, 2026
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what investors should know. Omnicell beat an...
Via StockStory · July 28, 2026